Search by Drug Name or NDC
NDC 50458-0308-11 RISPERDAL CONSTA Details
RISPERDAL CONSTA
RISPERDAL CONSTA is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is .
MedlinePlus Drug Summary
Risperidone extended-release (long-acting) injection is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Risperidone extended-release injection is used alone or in combination with lithium (Lithobid) or valproate (Depacon) to treat people who have bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of severe mania, and other abnormal moods). Risperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
Related Packages: 50458-0308-11Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Risperidone Injection
Product Information
NDC | 50458-0308 |
---|---|
Product ID | 50458-308_0a342d67-f908-9269-e063-6294a90ace24 |
Associated GPIs | 5907007010G240 |
GCN Sequence Number | 052936 |
GCN Sequence Number Description | risperidone microspheres VIAL 50 MG/2 ML INTRAMUSC |
HIC3 | H7T |
HIC3 Description | ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST |
GCN | 20219 |
HICL Sequence Number | 025509 |
HICL Sequence Number Description | RISPERIDONE MICROSPHERES |
Brand/Generic | Brand |
Proprietary Name | RISPERDAL CONSTA |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | risperidone |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | Janssen Pharmaceuticals, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021346 |
Listing Certified Through | 2024-12-31 |
Package
NDC 50458-0308-11 (50458030811)
NDC Package Code | 50458-308-11 |
---|---|
Billing NDC | 50458030811 |
Package | 1 KIT in 1 BOX (50458-308-11) * 2 mL in 1 VIAL * 2 mL in 1 SYRINGE |
Marketing Start Date | 2003-10-29 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 1178.79 |
Pricing Unit | EA |
Effective Date | 2023-10-13 |
NDC Description | RISPERDAL CONSTA 50 MG VIAL |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 2, 5 |
Classification for Rate Setting | B |
As of Date | 2024-02-21 |